LOS ANGELES: In the first lawsuit of its kind a gay lobby group has filed a claim against an insurance company for discrimination for denying a gay man long-term care insurance because he is taking Truvada (tenofovir/FTC) as pre-exposure prophylaxis (PrEP).
Truvada is a prescription combination of two antiretroviral drugs, emtricitabine and tenofovir, and is manufactured by Gilead. When used with other HIV medicines, Truvada can lower an HIV-infected patient’s viral load by keeping HIV from replicating…